Q32 Bio Inc.

NASDAQ (USD): Q32 Bio Inc. (QTTB)

Last Price

1.55

Today's Change

-0.045 (2.82%)

Day's Change

1.52 - 1.62

Trading Volume

84,099

Overview

Market Cap

18 Million

Shares Outstanding

12 Million

Avg Volume

154,248

Avg Price (50 Days)

1.75

Avg Price (200 Days)

15.95

PE Ratio

-0.20

EPS

-7.57

Earnings Announcement

06-Aug-2025

Previous Close

1.59

Open

1.57

Day's Range

1.52 - 1.62

Year Range

1.38 - 53.79

Trading Volume

84,443

Price Change Highlight

1 Day Change

-2.82%

5 Day Change

-3.73%

1 Month Change

-4.32%

3 Month Change

-25.12%

6 Month Change

-52.01%

Ytd Change

-55.07%

1 Year Change

-89.92%

3 Year Change

-96.17%

5 Year Change

-99.45%

10 Year Change

-99.54%

Max Change

-99.54%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment